CompaniesAoxing Pharmaceutical

Aoxing Pharmaceutical

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (7)
View all

Total Trials

7

As Lead Sponsor

2

As Collaborator

5

Total Enrollment

1,234

By Phase

PHASE4: 3NA: 1PHASE1: 1PHASE2: 1

By Status

COMPLETED: 6UNKNOWN: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
NCT01759836
NCT04871321
Hover over trial bars to see details

Recent Trials

NCT04871321Collaborator
Biomarker Discovery in Patients With Advanced Biliary Tract Cancer
N/ACompleted
119 participants
Started: Apr 14, 2021 · Completed: Dec 31, 2023
NCT03542721Lead Sponsor
Effect of DA-5515 (Circulan® Soft Cap.) in Patients With Chronic Fatigue Symptoms Due to Impaired Blood Circulation
PHASE4Unknown
204 participants
Started: Jan 17, 2018 · Completed: Dec 31, 2019
NCT03117153Lead Sponsor
Effect of a Liquid Toothpaste on Periodontal Disease
NACompleted
98 participants
Started: Aug 4, 2014 · Completed: Feb 11, 2015
NCT02100917Collaborator
Bioequivalence Study Evaluating the Pharmacokinetics of DMB-3111 and Trastuzumab in Healthy Japanese Male Adults
PHASE1Completed
70 participants
Started: Jan 31, 2014 · Completed: Dec 31, 2014
NCT01759836Collaborator
Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer
PHASE2Completed
364 participants
Started: Oct 31, 2012 · Completed: Sep 30, 2021
View all 7 trials →
Funding History (20)
8-K
Sep 25, 2017
Filing
8-K
Aug 4, 2017
Filing
8-K
Jun 22, 2017
Filing
DEFA14A
May 11, 2017
Filing
DEF 14A
May 11, 2017
Filing
8-K
Jun 23, 2016
Filing
DEFA14A
May 3, 2016
Filing
DEF 14A
May 3, 2016
Filing
8-K
Feb 1, 2016
Filing
8-K
Jan 11, 2016
Filing
Related Companies
Cyclo Therapeutics
merged